牛痘病毒 A35R 抑制 MHC Ⅱ类抗原呈递。
Vaccinia virus A35R inhibits MHC class II antigen presentation.
机构信息
Brody School of Medicine at East Carolina University, Department of Microbiology and Immunology, Greenville, NC, USA.
出版信息
Virology. 2010 Feb 5;397(1):176-86. doi: 10.1016/j.virol.2009.11.008. Epub 2009 Dec 2.
Abstract
The Vaccinia virus gene A35R (Copenhagen designation) is highly conserved in mammalian-tropic poxviruses and is an important virulence factor, but its function was unknown. We show herein that A35 does not affect viral infectivity, apoptosis induction, or replication; however, we found that A35 significantly inhibited MHC class II-restricted antigen presentation, immune priming of T lymphocytes, and subsequent chemokine and cytokine synthesis. A35 localized to endosomes and reduced the amount of a model antigenic peptide displayed in the cleft of class II MHC. In addition, A35 decreased VV specific T cell responses in vivo. Thus, this is the first report identifying a function for the A35 protein in virulence as well as the first report identifying a VV gene that inhibits peptide antigen presentation.
摘要
痘苗病毒 A35R 基因（哥本哈根命名）在哺乳动物亲和痘病毒中高度保守，是一个重要的毒力因子，但它的功能未知。本文显示，A35 不影响病毒感染力、凋亡诱导或复制；然而，我们发现 A35 显著抑制 MHC Ⅱ类限制性抗原呈递、T 淋巴细胞免疫启动以及随后的趋化因子和细胞因子合成。A35 定位于内体，并减少了 II 类 MHC 裂隙中显示的模型抗原肽的量。此外，A35 降低了 VV 特异性 T 细胞在体内的反应。因此，这是首次报道 A35 蛋白在毒力中的作用，也是首次报道抑制肽抗原呈递的 VV 基因。
相似文献
1
Vaccinia virus A35R inhibits MHC class II antigen presentation.牛痘病毒 A35R 抑制 MHC Ⅱ类抗原呈递。
Virology. 2010 Feb 5;397(1):176-86. doi: 10.1016/j.virol.2009.11.008. Epub 2009 Dec 2.
2
Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II.牛痘病毒降低了主要组织相容性复合体（MHC）II 类抗原的呈递、T 细胞的启动和与 MHC II 类结合的肽。
Immunology. 2009 Nov;128(3):381-92. doi: 10.1111/j.1365-2567.2009.03120.x.
3
Virus-encoded ectopic CD74 enhances poxvirus vaccine efficacy.病毒编码的异位 CD74 增强痘病毒疫苗的效力。
Immunology. 2014 Apr;141(4):531-9. doi: 10.1111/imm.12210.
4
The poxvirus A35 protein is an immunoregulator.痘病毒 A35 蛋白是一种免疫调节剂。
J Virol. 2010 Jan;84(1):418-25. doi: 10.1128/JVI.01802-09.
5
Disruption of MHC class II-restricted antigen presentation by vaccinia virus.痘苗病毒对MHC II类限制性抗原呈递的破坏作用。
J Immunol. 2005 Nov 15;175(10):6481-8. doi: 10.4049/jimmunol.175.10.6481.
6
Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II.牛痘病毒感染可诱导树突状细胞成熟，但会抑制MHC II类分子的抗原呈递。
Cell Immunol. 2007 Apr;246(2):92-102. doi: 10.1016/j.cellimm.2007.06.005. Epub 2007 Aug 2.
7
Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo.稳定抗原在体内经 DNA 疫苗接种和重组痘苗病毒感染后诱导 CD8+ T 细胞应答最为有效。
J Virol. 2012 Sep;86(18):9782-93. doi: 10.1128/JVI.00694-12. Epub 2012 Jul 3.
8
An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.痘苗病毒感染细胞中用于将细胞质抗原呈递给II类限制性T细胞的内源性加工途径。
J Exp Med. 1990 Sep 1;172(3):947-54. doi: 10.1084/jem.172.3.947.
9
Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class I molecules.牛痘病毒能逃避细胞毒性T淋巴细胞（CTL）的识别，并抑制MHC I类分子的细胞内运输。
J Immunol. 2007 Feb 1;178(3):1654-61. doi: 10.4049/jimmunol.178.3.1654.
10
Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison.外源性抗原对MHC I类和II类呈递途径的负载：体内定量比较
J Immunol. 2004 May 15;172(10):6129-35. doi: 10.4049/jimmunol.172.10.6129.
引用本文的文献
1
Vaccinia Virus-A Swiss Army Knife Against Cancer.痘苗病毒——对抗癌症的瑞士军刀。
Cancers (Basel). 2025 Jul 12;17(14):2324. doi: 10.3390/cancers17142324.
2
Temporal expression classes and functions of vaccinia virus and mpox (monkeypox) virus genes.痘苗病毒和猴痘病毒基因的时间表达类别及功能
mBio. 2025 Apr 9;16(4):e0380924. doi: 10.1128/mbio.03809-24. Epub 2025 Mar 20.
3
Navigating monkeypox: identifying risks and implementing solutions.应对猴痘：识别风险并实施解决方案。
Open Vet J. 2024 Dec;14(12):3144-3163. doi: 10.5455/OVJ.2024.v14.i12.1. Epub 2024 Dec 31.
4
An Attenuated and Highly Immunogenic Variant of the Vaccinia Virus.痘苗病毒的一种减毒且高免疫原性变体。
Acta Naturae. 2024 Apr-Jun;16(2):82-89. doi: 10.32607/actanaturae.27384.
5
The monkeypox virus-host interplays.猴痘病毒与宿主的相互作用。
Cell Insight. 2024 Jul 14;3(5):100185. doi: 10.1016/j.cellin.2024.100185. eCollection 2024 Oct.
6
A comprehensive review of monkeypox virus and mpox characteristics.猴痘病毒与猴痘特征的全面综述。
Front Cell Infect Microbiol. 2024 Mar 6;14:1360586. doi: 10.3389/fcimb.2024.1360586. eCollection 2024.
7
Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact.溶瘤病毒 VV-GMCSF-Lact 感染胶质瘤细胞后的转录组变化
Cells. 2023 Nov 12;12(22):2616. doi: 10.3390/cells12222616.
8
Selective events at individual sites underlie the evolution of monkeypox virus clades.个别位点的选择性事件是猴痘病毒进化枝进化的基础。
Virus Evol. 2023 May 20;9(1):vead031. doi: 10.1093/ve/vead031. eCollection 2023.
9
Comprehensive literature review of monkeypox.猴痘的全面文献综述。
Emerg Microbes Infect. 2022 Dec;11(1):2600-2631. doi: 10.1080/22221751.2022.2132882.
10
Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus.2022 年多国猴痘病毒爆发的系统基因组特征及微观进化迹象。
Nat Med. 2022 Aug;28(8):1569-1572. doi: 10.1038/s41591-022-01907-y. Epub 2022 Jun 24.
本文引用的文献
1
Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II.牛痘病毒降低了主要组织相容性复合体（MHC）II 类抗原的呈递、T 细胞的启动和与 MHC II 类结合的肽。
Immunology. 2009 Nov;128(3):381-92. doi: 10.1111/j.1365-2567.2009.03120.x.
2
The poxvirus A35 protein is an immunoregulator.痘病毒 A35 蛋白是一种免疫调节剂。
J Virol. 2010 Jan;84(1):418-25. doi: 10.1128/JVI.01802-09.
3
Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge.长期疫苗对艾滋病的保护作用以及在接受SHIV89.6P攻击后病毒DNA的清除情况。
Vaccine. 2009 Feb 11;27(7):979-86. doi: 10.1016/j.vaccine.2008.12.017. Epub 2009 Jan 7.
4
Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: an investigation of potential fomites in the home environment.由天花疫苗接种者传播牛痘病毒导致的种痘性湿疹：家庭环境中潜在污染物的调查
Vaccine. 2009 Jan 14;27(3):375-7. doi: 10.1016/j.vaccine.2008.11.019. Epub 2008 Nov 21.
5
Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons.痘苗病毒可阻断由I型和II型干扰素诱导的Stat1依赖性和Stat1非依赖性基因表达。
J Interferon Cytokine Res. 2008 Jun;28(6):367-80. doi: 10.1089/jir.2007.0113.
6
Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination.E3L基因发生突变的痘苗病毒作为具有潜在复制能力的减毒疫苗：鼻内接种。
Vaccine. 2008 Jan 30;26(5):664-76. doi: 10.1016/j.vaccine.2007.11.045. Epub 2007 Dec 4.
7
Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II.牛痘病毒感染可诱导树突状细胞成熟，但会抑制MHC II类分子的抗原呈递。
Cell Immunol. 2007 Apr;246(2):92-102. doi: 10.1016/j.cellimm.2007.06.005. Epub 2007 Aug 2.
8
B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.缺乏B5的痘苗病毒作为在痘苗免疫动物中表达外源抗原的疫苗载体。
Virology. 2007 May 10;361(2):356-63. doi: 10.1016/j.virol.2006.11.020. Epub 2006 Dec 26.
9
Direct CD28 costimulation is required for CD8+ T cell-mediated resistance to an acute viral disease in a natural host.在天然宿主中，CD8⁺ T细胞介导的对急性病毒病的抵抗力需要CD28共刺激。
J Immunol. 2006 Dec 1;177(11):8027-36. doi: 10.4049/jimmunol.177.11.8027.
10
Heterologous priming-boosting with DNA and modified vaccinia virus Ankara expressing tryparedoxin peroxidase promotes long-term memory against Leishmania major in susceptible BALB/c Mice.用表达锥虫硫氧还蛋白过氧化物酶的DNA和改良安卡拉痘苗病毒进行异源初免-加强免疫可促进易感BALB/c小鼠对硕大利什曼原虫的长期记忆。
Infect Immun. 2007 Feb;75(2):852-60. doi: 10.1128/IAI.01490-06. Epub 2006 Nov 13.
Zotero 插件